GLP2 – Trizepatide 30mg
This product is a once-weekly subcutaneous injection for treating Type 2 Diabetes and managing weight.
- The description claims significant weight reduction in clinical trials.
- The product activates both GIP and GLP-1 hormone receptors.
Specifications
- Weight
- 30mg, 60mg
AI Readiness
Good foundation, but some important product data is still missing.
61%